Objectives: Postoperative administration of corticosteroids is common practice for managing catecholamine refractory low cardiac output syndrome. Since corticosteroid activity is dependent on the glucocorticoid receptor, we sought to characterize glucocorticoid receptor levels in children undergoing cardiac surgery and examined the association between glucocorticoid receptor levels and cardiovascular dysfunction. Design: Prospective observational cohort study. Setting: Large, tertiary pediatric cardiac center. Subjects: Children undergoing corrective or palliative cardiac surgery. Interventions: None. Measurements and Main Results: A prospective observational cohort study was conducted in 83 children with congenital heart disease. Total glucocorticoid receptor levels were measured in the peripheral WBCs using flow cytometry. In addition, blood samples were collected for total cortisol levels. The primary outcome studied was the time to being inotrope free. An increase in glucocorticoid receptor level from postoperative day 1 to postoperative day 3 was associated with a longer time to being inotrope free (hazard ratio, 0.49 [0.29-0.81]; p = 0.01) in the univariate analysis. This association remained significant after adjusting for age, weight, cardiopulmonary bypass time, cross clamp time, Risk Adjustment for Congenital Heart Surgery-1 score, and postoperative steroid use (hazard ratio, 0.53 [0.29-0.99]; p = 0.05). Postoperative day 3 glucocorticoid receptor level showed a trend to have longer time to being inotrope free (hazard ratio, 0.66 [0.42-1.02]; p = 0.0.06). The cortisol levels minimally increased during the study duration and did not correlate with glucocorticoid receptor levels. Conclusions: Increasing glucocorticoid receptor levels in peripheral WBCs of children undergoing cardiac surgery are associated with a longer time to being inotrope free. Cortisol levels minimally increased during the study duration. These results suggest that exposure to high-dose perioperative corticosteroids may suppress the hypothalamic-pituitary-adrenal axis leading to increase in glucocorticoid receptor levels in response to a low cortisol environment. Further studies are required to better delineate the interplay between glucocorticoid receptor levels, cortisol levels, corticosteroid exposure, and postoperative inotropic requirements. (Pediatr Crit Care Med 2018; 19:705-712) Key Words: adrenal insufficiency; cardiac surgery; glucocorticoid receptor; low cardiac output syndrome; methylprednisolone; steroids C ardiac surgery for congenital heart disease has evolved significantly in the last decades with complex repairs being possible with relatively lower mortality rates; however, complications continue to occur frequently. One of the prevalent complications is Low Cardiac Output Syndrome (LCOS) (1-3). LCOS is defined as decreased cardiac index in the early postoperative stage and is associated with higher vasoactive medication requirement, greater ventilator days, longer ICU stay, and increased mortality (4). Although the etiology of LCOS varies, the initial management uniformly includes IV administration of fluids and vasoactive medications. Interestingly, there is a subset of patients who appear to have a suboptimal response to vasoactive agents, and some have speculated *See also p. 777. that such patients may have a degree of adrenal dysfunction and administration of corticosteroids may be beneficial.
C ardiac surgery for congenital heart disease has evolved significantly in the last decades with complex repairs being possible with relatively lower mortality rates; however, complications continue to occur frequently. One of the prevalent complications is Low Cardiac Output Syndrome (LCOS) (1) (2) (3) . LCOS is defined as decreased cardiac index in the early postoperative stage and is associated with higher vasoactive medication requirement, greater ventilator days, longer ICU stay, and increased mortality (4) . Although the etiology of LCOS varies, the initial management uniformly includes IV administration of fluids and vasoactive medications. Interestingly, there is a subset of patients who appear to have a suboptimal response to vasoactive agents, and some have speculated that such patients may have a degree of adrenal dysfunction and administration of corticosteroids may be beneficial. However, the precise etiology of adrenal dysfunction in this patient population is not known. Studies involving pediatric septic shock patients suggest that there exists a group of patients who may be less responsive to corticosteroids based on repression of genes corresponding to the glucocorticoid receptor (GCR) signaling pathway (5, 6) . Furthermore, preliminary data in critically ill children suggest that GCR expression varies widely and that decreased GCR expression is associated with increased cardiovascular and other organ dysfunction (7) .
Glucocorticoids modify metabolic, immune, and cardiovascular functions. The biological function of glucocorticoids is mediated through the activation of intracellular GCR. The GCR is part of the superfamily of steroid/thyroid/retinoid acid receptor proteins that function as ligand-dependent transcription factors (8) (9) (10) . GCR is required for receptor translocation from the cytoplasm to the nucleus to affect gene expression (11, 12) .
Until recently, the only way to measure glucocorticoid activity in critically ill patients was through cosyntropin stimulation test, but our laboratory has developed a new technique for measuring GCR expression in WBCs using flow cytometry (7) . We, therefore, sought to characterize GCR expression in peripheral WBCs in children undergoing cardiac surgery using this technique and to examine how GCR expression relates to cardiovascular dysfunction in this cohort.
METHODS

Patient and Data Collection
The study protocol was approved by Cincinnati Children's Hospital Medical Center (CCHMC) Institutional Review Board. Written informed consent was obtained from a parent or a legal guardian. This observational study was designed such that no added intervention will be given to the patients, instead patients receiving routine care as per CCHMC protocol will be followed prospectively between July 1, 2015, and January 31, 2016, and based on sample size calculation, 83 subjects were enrolled. The patient enrollment was not disclosed to the care providers in the ICU during the study period.
Subjects requiring corrective or palliative cardiac surgery with cardiopulmonary bypass (CPB) and admitted to the cardiac ICU (CICU) at CCHMC with an indwelling catheter (central venous catheter or an arterial catheter) were included. Those without informed consent, no central access available, or underwent cardiac surgery without CPB were excluded.
Blood samples for GCR flow cytometry and serum cortisol levels were obtained after central access placement either in the operating room before surgery or on the morning of surgery prior to the perioperative administration of methylprednisolone in hospitalized patients. Subsequent blood samples were then drawn at 24 and 72 hours after surgery. Clinical and other laboratory data were recorded daily until hospital discharge or 28 days (which ever occurred later). All study subjects received a dose of 30 mg/kg of methylprednisolone as per CCHMC protocol at the time of CPB initiation to blunt the inflammatory response.
Laboratory Procedure
GCR expression was measured with flow cytometry. In brief, after obtaining whole blood samples, the WBC count was determined, and 1 × 10 6 cells are mixed with lysis buffer to remove RBCs (Life Technologies, Carlbad, CA). After centrifugation and wash steps, cells were incubated with human serum as a blocking step. After blocking and a series of washes, aliquots of cells were incubated with specific immunoglobulin G (IgG) against human leukocyte subset markers (Becton Dickson, Valencia, CA). Each antibody was conjugated to a unique fluorophore for cell staining. After incubation with the cell surface antibodies and fixation in 2% paraformaldehyde, cells were permeabilized using a saponin-based buffer in order to measure surface (minimal) and intracellular (majority) GCR levels. At this point, a second human serum blocking step was completed and then incubated with either a mouse anti-GCR IgG diluted 1:50 (Thermo Scientific, Waltham, MA) or an isoform control mouse IgG1 diluted 1:10 (Abcam ab1264, Cambridge, United Kingdom). After incubation, cells were again fixed in 2% paraformaldehyde and stored in the dark until used for flow cytometry.
All flow cytometry procedures were conducted in the CCHMC flow cytometry core facility, counting 1 × 10 4 events for each antibody combination. Flow cytometry data were collected on BD Canto using FACSDiva v6.1.3 software (Becton Dickinson, Valencia, CA) and analyzed using Flowjo (Treestar, Ashland, OR). We controlled for nonspecific staining by using an isoform control IgG and gating based on fluorescence minus one (FMO), meaning that all antibodies are included except for the anti-GCR IgG. Gating was established using FMO. We used MFI for quantifying GCR expression levels, corrected for the respective FMO mean fluorescent intensity. Cortisol levels were measured using the Access Immunoassay Systems (Beckman Coulter, Inc., Brea, CA) with a potential cross-reactivity with prednisolone of 7%.
Endpoints and Outcome Assessment
The primary outcome studied was the time to being inotrope free (TIF) defined as the time in days from surgery to the first day the subject was completely off inotropic agents. TIF is the equivalent to "inotropic support use" and "inotropic free days" commonly evaluated in cardiology, cardiac surgery, and critical care studies in adults (13, 14) . TIF or inotropic support use has been associated with outcomes in critically ill children but has not been assessed in children undergoing cardiac surgery. This endpoint was chosen because mortality rates in congenital cardiac surgery are low outside of patients undergoing single ventricle palliation, and based on sample size calculation, it would have required a much larger sample to conduct a single-institution study.
The secondary outcome was LCOS, and for this study, LCOS for postoperative day (POD) 1 (POD 1 arrival from the operating room to the CICU until midnight), POD 2, and POD 3 was studied and was classified into five categories as "mild": single vasoactive agent or arterial lactate less than 2; "moderate": two vasoactive agents or arterial lactate between 2 and 5; "severe": three or more vasoactive agents or arterial lactate greater than 5; "mechanical support": requirement of extracorporeal membrane oxygenation (ECMO) or ventricular assist devices (VADs); and finally, "death." This endpoint was chosen because elevated lactate levels and more number of vasoactive agents with higher dosage have been associated with worse clinical outcomes (1, 15, 16) .
Statistical Analysis
Categorical variables were presented as frequency counts and percentages, and continuous variables as medians and interquartile range (IQR). The independent variables, GCR, and cortisol were examined individually for each of the 3 study days (preoperative, POD 1, and POD 3). In addition, GCR was examined as an absolute change in levels between the 3 study days. Based on positive or negative change in GCR between the 2 study days, binary categorical variables as increase versus decrease in GCR levels between the study days were created to examine survival curves, and Kaplan-Meier curves were plotted to show the relationship between TIF, as time to event outcome, and change in GCR levels (increase vs decrease). Univariate and multivariable Cox proportional hazard models were developed to examine TIF in relation to GCR and cortisol. Multivariable models for TIF and GCR were adjusted for age, weight, CPB time, cross clamp time, Risk Adjustment for Congenital Heart Surgery (RACHS)-1 score, and postoperative hydrocortisone use which were found to be significant factors in the univariate analysis, and results were presented as hazard ratio (HR) and 95% CI. HRs greater than one were favorable in this study since shorter TIF was beneficial (as opposed to longer time being beneficial in usual survival models). The multivariable models for TIF and cortisol were adjusted for all covariates as for GCR, except postoperative hydrocortisone use because interaction between cortisol and postoperative hydrocortisone use was not significant. For statistical analysis, LCOS was regrouped into three categories by collapsing mechanical support and death into severe category because of low frequency counts. Association between TIF and LCOS scores as mild, moderate, and severe for each individual POD (POD 1, POD 2, and POD 3) was examined using Cox model, and HRs were presented; HR greater than one indicating shorter TIF and beneficial for this study. For secondary outcome as LCOS, proportional odds cumulative logit models accounting for repeated measures were developed, and cumulative odds for severe and moderate LCOS versus mild was examined, and GCR and cortisol levels were the independent variables. All p values were calculated for two-tailed test, with statistical significance set at p value of less than or equal to 0.05.
RESULTS
Eighty-three consecutive patients were enrolled and examined. The demographic characteristics of the subjects are shown in Supplemental Table 1 (Supplemental Digital Content 1, http:// links.lww.com/PCC/A651). The majority of the patients were infants (63%) with a median age 5.1 month (IQR, 0.5-43.6 mo) and were males (63%). The most frequent diagnoses were conotruncal abnormalities (28%) and left-sided obstructed lesions (24%). Only two patients required ECMO/VAD, and 19% developed acute kidney injury. At POD 1, 13 of 83 patients (15.6%), POD 2, 18 of 83 patients (21.7%), and POD 3, 18 of 83 patients (21.7%) received postoperative hydrocortisone. The median TIF was 3 days (IQR, 1-5 d), and mortality was observed in three patients (3.6%). Change in GCR and cortisol levels over time is presented as Supplemental Figure 1 The total cortisol level determination was found to have a wide range of distribution (Supplemental Table 1 , Supplemental Digital Content 1, http://links.lww.com/PCC/A651). The median cortisol level increased from 12.4 μg/dL preoperatively to 14.4 μg/dL on POD 1 and 20.6 μg/dL on POD 3. Comparing TIF with cortisol on each study day, in both univariate and multivariable analyses, higher cortisol levels were associated with longer TIF (Table 1) . Comparing LCOS categories with cortisol, higher cortisol levels on POD 1 were significantly associated with higher LCOS categories (Table 3) . A trend was seen for negative correlation between GCR and cortisol levels preoperatively, and no significant correlation was identified between GCR levels and cortisol levels on POD 1 and POD 3 (Fig. 2) .
DISCUSSION
In this study, we characterized the GCR levels in WBCs of children undergoing cardiac surgery requiring CPB and present their associations with clinical outcomes. The rationale for this study was the fact that cortisol levels have demonstrated low correlation with clinical outcomes in this patient population.
Our findings demonstrated a continuous increase in GCR levels throughout the first 72 hours following cardiac surgery. The increase in GCR level on POD 3 and increased levels between POD 1 and POD 3 were associated with longer TIF. Although the characterization of GCR in children undergoing cardiac surgery has not been documented until now, our findings were somewhat unexpected because studies in critically ill children and adults have demonstrated a decrease in GCR levels to be associated with more cardiovascular dysfunction and other organ failure (17) (18) (19) . The divergence of our findings from previous studies in noncardiac patients may be explained by perioperative corticosteroids administration for CPB in children undergoing cardiac surgery and suggests an intricate interdependence between GCR levels and steroid exposure.
GCR regulation is a complex process and is influenced by several factors present during cardiac surgery in children. For instance, the duration of the exposure to corticosteroid has been shown to modify GCR levels (20) . The majority of animal and human studies have demonstrated that a brief corticosteroid exposure causes decreased levels of GCR (21-24) ; however, Adjusted for all covariates as for GCR except postoperative hydrocortisone use. All independent variables are continuous in nature except for increase vs decrease in GCR, which were derived based on positive or negative change in GCR levels between study days. Shorter time to being inotrope free (TIF) was beneficial in this study (as opposed to longer time being good in usual survival models); therefore, HR >1 is favorable for this study. HR < 1 indicates longer TIF in relation to increase in GCR or cortisol levels for each study day or in relation to absolute change or increase vs decrease in GCR between study days. other studies have demonstrated that continuous presence of corticosteroids leads to an increase in GCR levels (20, 25, 26) . There is a possibility that hormone-level specific modulation could be a mechanism for cells to adapt to changes in the hormonal environment, although this mechanism has not been thoroughly studied. In addition, target organs modify GCR levels during specific situations such as infection, cancer, or surgery. Sun et al (27) demonstrated increased GCR levels by studying protein and messenger RNA assessment in skeletal muscle of a rat model of sepsis and demonstrated that increased GCR levels augmented hormone-binding activity during the catabolic response in sepsis. Al-Mohaisen et al (28) also demonstrated increased GCR levels in hepatic cells of rats exposed to acute and repeated immobilization stress and suggested that the increase in GCR levels may be an adaptive response for survival during stress. Thus, the interdependence between GCR levels, corticosteroid dose, and duration of exposure may be different depending on the cell types and tissues under diverse stress conditions. In terms of the secondary outcome, we identified that higher GCR levels in general were associated with lower LCOS categories during the first 72 hours postoperatively. However, the continuous increase in GCR levels was associated with longer TIF. Although a precise biological explanation for these findings is not available, other molecular mechanisms not analyzed during this study may participate in the interaction between cardiac function and the hypothalamic-pituitary-adrenal axis. For instance, the neuregulin-1 and the erythroblastic leukemia viral oncogene homolog (ErbB) play a critical role in the regulation of the hypothalamic-pituitary-adrenal axis activity and neurocardiac response to pathologic stress (29) . Specifically, the neuregulin-1/ErbB pathway activation response can be biphasic, characterized by an initial adaptation phase that may protect the myocardium, followed by a maladaptive phase leading to disease progression (30, 31) .
We also measured total cortisol levels in all subjects. Based on current definitions of adrenal insufficiency, the cortisol levels in general were suppressed and minimally increased following cardiac surgery. It has been shown that high-dose perioperative corticosteroid treatment for CPB is associated with suppressed serum cortisol levels (32) . However, suppressed cortisol levels are particularly important in our study since all subjects received one dose of perioperative corticosteroids to blunt the stress response induced by CPB. Hence, our results may suggest that exposure to high-dose perioperative corticosteroids suppresses the hypothalamic-pituitary-adrenal axis and increases GCR levels as a result of a low cortisol environment. We also identified that higher cortisol levels were associated with longer TIF and higher LCOS scores. Although methylprednisolone is a selective GCR agonist, exposure to high-dose corticosteroids and the endogenous glucocorticoid production may have activated both mineralocorticoid receptor (MR) as well as GCR (33) . In fact, MR binds corticosteroids with comparable affinity, in contrast to GCR which binds glucocorticoids with higher affinity than aldosterone. Ultimately, excessive activation of the MR may contribute to cardiac dysfunction and has been associated with increased occurrence of heart failure (34, 35) . Further studies are required to better delineate the interplay among corticosteroid exposure, cortisol, and MR levels.
The primary limitations of the study include that WBCs were used to quantify GCR levels under the assumption that they will be reflective of GCR levels in other tissues. The optimal approach would have been to quantify tissue GCR levels, but our study was designed to quantify GCR levels using a least invasive technique. The presence of GCR in cardiac cells has been determined (20, 23) , but whether GCR levels in WBCs correlates well with GCR levels at other end organ level needs further investigation. The increase GCR levels after corticosteroid exposure may be tissue dependent as demonstrated in human leukemic T-cell line, myeloma cells, and fibroblast from keloid tissue (36) (37) (38) . It is also important to indicate that the LCOS categories used for our study were based on perceptions of CICU providers and have not been rigorously validated (39) . Furthermore, the use of cardiovascular agent exposure as a criterion for LCOS classification might not be as useful particularly because some of the subjects in our study returned to the CICU on prophylactic vasoactive agents. Similarly, the duration of inotropic support may be an arbitrary time and dependent on the clinical and surgical staff caring for a patient. We attempted to minimize observer bias by blinding the clinical and surgical staff from the study. This study was powered to assess GCR performance in a heterogeneous population of children undergoing cardiac surgery and not for specific surgical repairs or palliations. The administration of glucocorticoids at the time of CPB initiation is considered standard of care at our institution; therefore, GCR levels were not determined on patients who did not receive them. Last, this is the first study examining association between TIF and GCR levels, and because TIF has not been standardized, the results of this study may not be generalizable.
In conclusion, analysis of peripheral WBCs of children undergoing cardiac surgery demonstrated an increase in GCR levels. The increase in GCR levels on POD 3 and between POD 1 and POD 3 was associated with a longer TIF. Cortisol levels minimally increased during the first 72 hours after surgery with no significant correlation with GCR levels. These findings may imply that peripheral WBCs of children undergoing cardiac surgery are less sensitive to the down-regulating effects of glucocorticoids and may predispose patients to the negative side-effects of high doses of glucocorticoid treatment.
